So, alongside his ultra-high-protein, low-carb diet, he started taking an ultra-powerful but not-yet-released GLP-1 drug called retatrutide, which is still in development at Eli Lilly, about three months ago
Importantly, these findings should not be extrapolated to newer dual incretin agonists such as tirzepatide
If such medications are to be administered with food, do not co-administer with SOLIQUA 100/33
In Part 1 we started discussing the study Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al
As advised by the labeling of the product and in a phone call to Mochi Health, she took a dose nine times too large, which caused a two-night stay in the hospital
Weight Management, Fertility, and Family Planning Weight and fertility are closely connected